- Home
- TNGX vs MDA Comparison
TNGX vs MDA Comparison
Compare TNGX & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | MDA |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | United States | Canada |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.2B |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | TNGX | MDA |
|---|---|---|
| Price | $23.35 | $34.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $21.78 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 2.8M | 545.8K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,384,000.00 | N/A |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $11.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $1.12 | $23.23 |
| 52 Week High | $28.41 | $37.45 |
Technical Indicators
Market Signals| Indicator | TNGX | MDA |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 58.40 |
| Support Level | $7.08 | $28.96 |
| Resistance Level | $28.41 | $37.45 |
| Average True Range (ATR) | 1.80 | 1.81 |
| MACD | -0.47 | 0.01 |
| Stochastic Oscillator | 34.51 | 79.78 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MDA MDA Space Ltd. Common Shares
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.